FoundationOne CDx (F1CDx)

2 trials

Sponsors

Bristol-Myers Squibb Company

Conditions

Metastatic Non-small Cell Lung Cancer Advanced Lung CancerUntreated Metastatic Pancreatic Ductal Adenocarcinoma Advanced pancreatic cancer

Unknown Phase

Research plan for using the FoundationOne®CDx test in clinical trial CA2400029

Active, not recruitingNL-OMON61258

Bristol-Myers Squibb CompanyMetastatic Non-small Cell Lung Cancer Advanced Lung Cancer

Start: 2025-11-28Target: 36Updated: 2026-06-22

Research plan for using the FoundationOne®CDx test in clinical trial CA2400030

Active, not recruitingNL-OMON61328

Bristol-Myers Squibb CompanyUntreated Metastatic Pancreatic Ductal Adenocarcinoma Advanced pancreatic cancer

Start: 2026-07-01Target: 25Updated: 2026-07-13